Geoffrey M. Curtis joined Horizon in 2015 and has more than two decades of global health care communications experience.
Before joining Horizon, Curtis served as senior vice president at Edelman Public Relations and as part of its National Health Media Team he led media strategy and execution for a large portfolio of pharmaceutical, biotech and medical device clients. He was responsible for developing and maintaining media relationships, as well as implementing media strategies to support regulatory and product milestones, data publication and global medical meetings.
Previously, Curtis was group director of the media practice at WCG, a W20 Group company, where he provided product and corporate communications counsel and handled ongoing media relations for a broad range of health care clients. Before WCG, he held a similar role at GCI Group.
Before joining GCI, Curtis served as a public affairs manager in the Pharmaceutical Products Division at Abbott (now AbbVie), where he led internal and external communications programs for the immunology, neuroscience and oncology franchises.
Curtis received a Bachelor of Arts in English from Lake Forest College in Lake Forest, Ill., and a Master of Arts from DePaul University in public relations and advertising. He serves on the boards of directors of the Illinois Science and Technology Coalition and Institute (ISTC/I) and the Child Restoration Outreach and Support Organization (CROSO) and is a member of the Lake Forest College board of trustees, as well as a trustee for the Institute for Public Relations.
What is Geoffrey M. Curtis' net worth?
The estimated net worth of Geoffrey M. Curtis is at least $12.03 million as of April 1st, 2021. Mr. Curtis owns 103,414 shares of Horizon Therapeutics Public stock worth more than $12,027,048 as of April 26th. This net worth estimate does not reflect any other assets that Mr. Curtis may own. Learn More about Geoffrey M. Curtis' net worth.
How old is Geoffrey M. Curtis?
Mr. Curtis is currently 48 years old. There are 5 older executives and no younger executives at Horizon Therapeutics Public. The oldest executive at Horizon Therapeutics Public is Mr. Timothy P. Walbert, Chairman, Pres & CEO, who is 56 years old. Learn More on Geoffrey M. Curtis' age.
How do I contact Geoffrey M. Curtis?
Has Geoffrey M. Curtis been buying or selling shares of Horizon Therapeutics Public?
Geoffrey M. Curtis has not been actively trading shares of Horizon Therapeutics Public during the last quarter. Most recently, Geoffrey M. Curtis sold 70,739 shares of the business's stock in a transaction on Thursday, April 1st. The shares were sold at an average price of $93.51, for a transaction totalling $6,614,803.89. Following the completion of the sale, the executive vice president now directly owns 103,414 shares of the company's stock, valued at $9,670,243.14. Learn More on Geoffrey M. Curtis' trading history.
Who are Horizon Therapeutics Public's active insiders?
Horizon Therapeutics Public's insider roster includes Brian Beeler (EVP), Daniel Camardo (EVP), Sean Clayton (EVP), Aaron Cox (CFO), Geoffrey Curtis (EVP), William Daniel (Director), Michael Desjardin (EVP), Michael Grey (Director), Paul Hoelscher (CFO), Vikram Karnani (EVP), Jeff Kent (Insider), Irina Konstantinovsky (EVP), Miles Mchugh (SVP), Barry Moze (EVP), Andy Pasternak (EVP), Jeffrey Sherman (EVP), Elizabeth Thompson (EVP), and Timothy Walbert (CEO). Learn More on Horizon Therapeutics Public's active insiders.
